Clinical studies
Clinical studies
Peer-reviewed research supporting each claim
Talbott et al. (2019)
12mg Hawaiian astaxanthin, 8 weeks, double-blind RCT. Depression scores reduced 57%, fatigue 36%, mood +11%.
View study →MDPI Systematic Review (2026)
Review of 15 human clinical trials. Astaxanthin consistently reduced IL-6, TNF-α, and TGF-β1 inflammatory markers.
View study →Ma et al. Meta-analysis (2022)
Meta-analysis of 12 RCTs, 380 participants. Astaxanthin significantly reduced MDA, the primary oxidative stress biomarker.
View study →Saito et al. (2016)
120 healthy subjects, 12-week double-blind RCT with actigraphy. Astaxanthin significantly improved sleep efficiency and sleep onset.
View study →These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.